Deutsch | English | Español | Français | Italiano | Português | Русский | العربية | 日本語 | 简体中文 | 繁體中文 | 한국의 | Türk | Polski
Global B2B Portal for Bio-Medical & Pharm Industry
Product / Service Supplier Catalogs & Literature    
home Product News Catalogs Web TV News & Topics Featured Articles Trade Shows Sourcing Help My allbiomedical
Keyword for News & Topics:
Market News, Trends and Topics
E-mail to Colleague Print
Two-Thirds of U.S. Residents Get Sufficient Vitamin D 2011-03-30
Author: ModernMedicine Staff
From: ModernMedicine
About two-thirds of the U.S. population takes in sufficient amounts of vitamin D, but 8 percent may be at risk for vitamin D deficiency, according to a March data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.
Hyperlink to Original Source

Antioxidant Formula Reduces Radiation Damage 2011-03-30
Author: Drug Discovery & Development Staff
From: Drug Discovery & Development
A unique formulation of antioxidants taken orally before imaging with ionizing radiation minimizes cell damage, noted researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill. In what the researchers say is the first clinical trial of its kind, as much
Hyperlink to Original Source

Human Genome Sciences inks cancer drug deal 2011-03-16
Author: Bioscience Technology Staff
From: Bioscience Technology
Drug developer Human Genome Sciences Inc. said Wednesday it has agreed with FivePrime Therapeutics Inc. to develop and bring to market a drug for treating several types of cancer. The drug, discovered by FivePrime and dubbed FP-1039, is being used to treat a variety of cancers in clinical trials.
Hyperlink to Original Source

Drug-Resistant TB May Lead to Cure 2011-03-07
Author: Drug Discovery & Development Staff
From: Drug Discovery & Development
New findings on how tuberculosis (TB) bacteria develop multi-drug tolerance point to ways TB infections might be cured more quickly.
Hyperlink to Original Source

Merck-Sanofi Deal Held Up by Regulators 2011-03-02
Author: Drug Discovery & Development Staff
From: Drug Discovery & Development
Drugmaker Merck & Co. said its planned venture with French counterpart Sanofi-Aventis SA to unite their animal health businesses has been delayed as regulators continue anti-trust reviews.
Hyperlink to Original Source

VaxInnate Wins $196M Flu Contract 2011-03-02
Author: Drug Discovery & Development Staff
From: Drug Discovery & Development
VaxInnate Corporation announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), worth up to $196 million to fund the development of recombinant seasonal and pandemic flu vaccine
Hyperlink to Original Source

Biomedical signal processor targets wearable biomedical sensor systems 2011-02-28
Author: Julien Happich
From: EE Times
Intelligent body area networks (BANs) consisting of wireless sensors nodes which continuously monitor vital body parameters such as heart, muscle and brain activity promise to be a solution for more comfortable, cost- and time-efficient healthcare systems. They allow people to be monitored and follo
Hyperlink to Original Source

HGS 4Q Loss Grows from Year Before 2011-02-25
Author: Drug Discovery & Development Staff
From: Drug Discovery & Development
Drug developer Human Genome Sciences Inc. reported a larger fourth-quarter loss as expenses related to its lupus drug candidate Benlysta grew, and revenue decreased. The company said it lost $87.6 million, or 46 cents per share. A year ago Human Genome Sciences lost $9.7 million, or 6 cents per shar
Hyperlink to Original Source

Mylan 4Q Profit Plummets 38% 2011-02-24
Author: Drug Discovery & Development Staff
From: Drug Discovery & Development
Generic drug maker Mylan Inc. said that its fourth-quarter profit fell 38 percent on higher costs and charges, but adjusted results meet Wall Street expectations. The company reported net income of $2.6 million, or a penny per share, for the three months ended Dec. 31, down from $4.1 million, or a p
Hyperlink to Original Source

Merck 4Q Earnings Drop 18% 2011-02-23
Author: Geir Moulson
From: Drug Discovery & Development
Fourth-quarter earnings at German drug and chemical maker Merck KGaA were down 18 percent due to the effect of deferred tax assets, but the company cheered investors by issuing an upbeat forecast for this year and next.
Hyperlink to Original Source

Note: The copyright and the ownship of the brand, product names, product numbers, and content mentioned belongs to their repective companies.
Update your allbiomedical products information to keep ahead with market trend.
Subscribe Now!!
View by Categories

Chemical and Material

Contract Manufacturing Services

Cosmetics and Beauty Supplies

Dental Products

Electromedical Diagnostics Equipment

Healthcare Products and Nutritional Supplement

Hospital, Lab and Clean Room Equipment

In-vitro Diagnostics

Manufacturing Equipment

Medical and Surgery Supplies

Medical Imaging

Medical Instrument Components

Medical IT

Medicine, Vaccine and Drug Delivery Systems

Packaging, Labelling, Printing, Barcoding

Pharmaceutical Machinery

Physiotherapy/Orthopaedic Equipment

Services for Medical Industry

Surgery and Endoscopy

Therapy and Physical Medical Devices
My Allbiomedical
Take advantage of the benefits of My %%webname%%
- Track your sourcing projects
- View your search history
- Create a contact list
- Get latest new products and suppliers
- Send inquiries direct to suppliers
- Submit press release, and download detailed suppliers profiles, product profiles, and CAD drawing

Sign-up FREE Now
Featured Articles
Featured Pages
· Home
· Product News
· Catalogs
· Web TV
· News & Topics
· Features Articles
· Trade Show
· Sourcing Help
· My Allbiomedical
Special Zone
· Directory
· Trade Show Supplement
· About Us
· Promote Your Business
· Advertise
· Partner with Us
· Press Release
· Contact Us
· Term of Use
· Privacy Policy
· Starter Program
· Sitemap
B2B Web Portal Alliance
Buy Engineer Sample Kits
OEM Sourcing
· Deutsch
· English
· Español
· Français
· Italiano
· Português
· Русский
· العربية
· 日本語
· 简体中文
· 繁體中文
· 한국의
· Türk
· Polski

Copyrights © 2012 Allitwares Corporation All Rights Reserved. is a Division of Allitwares Corporation is a B2B Trade Portal | B2B Web Portal |B2B Marketplace for biomedical and pharmaceutical industry